The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...
A new study suggests clinical utility of the first FDA-approved genetic test to help gauge an individual’s risk for opioid ...
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for ...
Websites that sell compounded glucagon-like peptide-1 receptor agonists often partially inform or misinform consumers.